Minimal Effective Dose for Strength: What the Research Actually Says

A landmark 2017 meta-analysis by Ralston et al. found that even one set per exercise per week produced significant strength gains in trained individuals — a finding that upended decades of high-volume convention. The question isn't whether low volume works; it's how low you can go before adaptation plateaus and what objective signals tell you you've crossed that threshold. This review synthesizes the strongest dose-response evidence and gives you specific numbers to program with.

Strength adapts along a nonlinear dose-response curve. The first 5–10 hard sets per muscle per week capture roughly 70–80% of the maximum achievable gain; the next 10 sets add the remaining 20–30% at increasing diminishing returns (Schoenfeld et al., 2017). This asymmetry is exactly why a minimal effective dose strategy is rational for athletes managing sport workload, not just convenient.

The curve steepens sharply below ~3 sets per muscle per week. Below this threshold, gains become inconsistent across individuals — not zero, but unreliable. Above ~20 sets per muscle per week, the evidence consistently shows no additional benefit and rising injury risk from cumulative fatigue (Krieger, 2010).

Ralston et al. (2017) pooled 43 studies and found that low-volume conditions (≤5 sets/week per muscle) produced strength increases averaging 12.6% over 8 weeks versus 16.7% for high-volume conditions — a meaningful gain for a fraction of the work. The catch: low-volume responders tended to be either highly trained individuals (where neuromuscular efficiency is already high) or beginners (where almost any stimulus works).

For intermediate athletes, the evidence tips toward 4–8 sets per muscle per week as the true minimal effective dose for consistent strength progress. Below 4 sets, outcome variance doubles, making it difficult to program confidently without individual response data.

Training status fundamentally shifts what counts as a minimal effective dose. The table below summarizes current evidence-based volume recommendations:

These ranges assume sets are taken within 2–3 reps of failure and performed with maximal intent. Volume that isn't hard enough to approach failure generates a different — and generally weaker — signal regardless of set count.

Dose-response research consistently shows that how hard a set is matters more than how many sets you perform once you're above the minimum threshold. Schoenfeld et al. (2021) compared equal volume at different proximities to failure and found that sets stopped 4+ reps short of failure produced 30–40% smaller strength gains than sets stopped 0–2 reps short. The implication: if you're cutting volume to find a minimal effective dose, you cannot simultaneously reduce effort level. Fewer, harder sets outperform more, easier sets in every well-controlled comparison.

Practically, this means your minimal effective dose protocol needs an objective stopping rule — not RPE alone, which is notoriously noisy in fatigued athletes.

Velocity-based training gives you a real-time indicator of cumulative intra-set fatigue that RPE cannot. Pareja-Blanco et al. (2017) demonstrated that sets terminated at 20% mean concentric velocity (MCV) loss produced strength gains statistically equivalent to sets taken to failure — while generating roughly half the metabolic and neuromuscular fatigue. Sets terminated at <10% velocity loss produced meaningful but smaller gains.

For minimal-dose programs specifically, the 20% velocity loss threshold acts as a precision stop rule: the set ends when it has delivered its training stimulus, not before and not after. This eliminates the risk of junk volume — sets that accumulate fatigue without adding stimulus — which is the primary hidden cost of low-volume approaches implemented without objective monitoring.

With PoinT GO's 800Hz IMU, you can monitor MCV on every rep across squats, deadlifts, bench press, and jump-based exercises, ensuring each session's dose is both sufficient and not wasteful. For minimal-dose strength programs, this is the difference between a method and a guess. Track your velocity-loss thresholds with PoinT GO — learn more at poin-t-go.com.

Mujika and Padilla (2000) demonstrated that 1–3 sets per muscle group per week at maintained intensity is sufficient to preserve off-season strength gains across an in-season period of 10–20 weeks. The critical variable is intensity — reducing load below 80% 1RM accelerates detraining even when set count is maintained. Volume can drop by 50–66% without strength loss; intensity cannot drop by more than 10–15% without measurable regression within 3–4 weeks.

For team sport athletes in-season, a practical minimum effective dose is 2 exercises per primary muscle group, 2–3 sets each, at 80–85% 1RM or equivalent velocity zone (0.60–0.75 m/s for squat patterns), twice per week. This fits within 30–40 minutes of gym time and preserves the neuromuscular base built in the off-season.

The following 2-day template represents a validated minimum effective dose for intermediate athletes. Velocity targets assume monitoring with an IMU sensor; RPE equivalents are provided for sessions without technology.

Rest 3–4 minutes between sets. Session duration should be 30–45 minutes. If bar velocity on the first set is more than 10% below the previous week's opening velocity, reduce load by 5% rather than forcing the target — this is the single most important in-session adjustment rule for low-volume programs.

Three errors account for most failures when reducing to a minimal effective dose:

• Reducing intensity simultaneously with volume. When both drop, the training stimulus falls below threshold for any detectable adaptation. Preserve load first; cut sets second.
• Removing frequency instead of sets. Dropping from 3 sessions to 1 session per week — while keeping set count per session — produces worse outcomes than spreading the same total sets across 2–3 sessions. Frequency maintains the protein synthesis signal that drives adaptation.
• Failing to track individual velocity responses. The dose-response curve is a population average. Some athletes require 8–10 sets per week to match what others achieve in 4–5. Without per-rep velocity data, you cannot distinguish an underdosed individual from an overdosed one — both can exhibit stalled progress.